Tau propagation is dependent on the genetic background of mouse strains.

Alzheimer’s disease cell-to-cell transfer genetic background tau spreading tauopathies

Journal

Brain communications
ISSN: 2632-1297
Titre abrégé: Brain Commun
Pays: England
ID NLM: 101755125

Informations de publication

Date de publication:
2022
Historique:
received: 10 09 2021
revised: 02 01 2022
accepted: 21 02 2022
entrez: 30 3 2022
pubmed: 31 3 2022
medline: 31 3 2022
Statut: epublish

Résumé

Progressive cognitive decline in Alzheimer's disease correlates closely with the spread of tau protein aggregation across neural networks of the cortical mantle. We tested the hypothesis that heritable factors may influence the rate of propagation of tau pathology across brain regions in a model system, taking advantage of well-defined genetically diverse background strains in mice. We virally expressed human tau locally in the hippocampus and the entorhinal cortex neurons and monitored the cell-to-cell tau protein spread by immunolabelling. Interestingly, some strains showed more tau spreading than others while tau misfolding accumulated at the same rate in all tested mouse strains. Genetic factors may contribute to tau pathology progression across brain networks, which could help refine mechanisms underlying tau cell-to-cell transfer and accumulation, and potentially provide targets for understanding patient-to-patient variability in the rate of disease progression in Alzheimer's disease.

Identifiants

pubmed: 35350555
doi: 10.1093/braincomms/fcac048
pii: fcac048
pmc: PMC8952249
doi:

Types de publication

Journal Article

Langues

eng

Pagination

fcac048

Subventions

Organisme : NIA NIH HHS
ID : RF1 AG059789
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007753
Pays : United States

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain.

Références

Cell Rep. 2016 Oct 18;17(4):931-940
pubmed: 27760323
Nat Genet. 2013 Dec;45(12):1452-8
pubmed: 24162737
Acta Neuropathol Commun. 2018 Nov 29;6(1):132
pubmed: 30497516
Ann Neurol. 2017 Aug;82(2):311-314
pubmed: 28727176
Alzheimers Dement (N Y). 2020 Nov 23;6(1):e12110
pubmed: 33283040
Front Aging Neurosci. 2019 Dec 11;11:343
pubmed: 31920624
Nat Med. 2020 Aug;26(8):1256-1263
pubmed: 32572268
Neuron. 2021 May 19;109(10):1657-1674.e7
pubmed: 33831349
Acta Neuropathol Commun. 2014 Jan 30;2:14
pubmed: 24479894
Neuropathol Appl Neurobiol. 2015 Feb;41(1):3-23
pubmed: 25495175
Acta Neuropathol. 2020 Jan;139(1):3-25
pubmed: 31686182
Genes Brain Behav. 2019 Nov;18(8):e12603
pubmed: 31381246
Sci Transl Med. 2021 Jan 20;13(577):
pubmed: 33472953
Mol Neurodegener. 2014 Jan 15;9:8
pubmed: 24428919
Nature. 2020 Apr;580(7803):381-385
pubmed: 32296178
Neuron. 2012 Feb 23;73(4):685-97
pubmed: 22365544
Adv Exp Med Biol. 2019;1184:305-325
pubmed: 32096046
Neuron. 2019 Feb 6;101(3):399-411.e5
pubmed: 30595332
Sci Rep. 2021 May 5;11(1):9623
pubmed: 33953293
PLoS Genet. 2019 May 31;15(5):e1008155
pubmed: 31150388
Methods Cell Biol. 2017;141:307-322
pubmed: 28882310
EMBO J. 2015 Dec 14;34(24):3028-41
pubmed: 26538322
Neurology. 2021 May 11;96(19):e2414-e2428
pubmed: 33771840
Cell Rep. 2021 Jun 8;35(10):109189
pubmed: 34107263
Mol Psychiatry. 2013 Nov;18(11):1225-34
pubmed: 23399914
Sci Adv. 2019 Jun 26;5(6):eaaw6404
pubmed: 31249873

Auteurs

Simon Dujardin (S)

Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA.
Harvard Medical School, Boston, MA, USA.

Analiese Fernandes (A)

Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA.

Riley Bannon (R)

Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA.

Caitlin Commins (C)

Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA.

Mark De Los Santos (M)

Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA.

Tarun V Kamath (TV)

Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA.

Mansuo Hayashi (M)

Eli Lilly and Company, Indianapolis, IN, USA.

Bradley T Hyman (BT)

Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA.
Harvard Medical School, Boston, MA, USA.

Classifications MeSH